iOmx Therapeutics

Cancer Care Centers · Drug Discovery

Overview

See how iOmx transforms deep tumor biology into breakthrough immunotherapies. Explore our pipeline, technology and careers — join us in advancing cancer care.

Funding and backers

Team
51-200
employees, estimated range
Backers
2
M Ventures, Sofinnova Partners
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Registers and programsofficial lists and records that name the company
Legal entity Omx Therapeutics AG its site
Backed byfrom the funds' portfolios and accelerator catalogs
M Ventures fund Sofinnova Partners fund
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Luminate Medical
Plug and Play
backs OncoBrain
8VC
backs Luminate Medical
F-Prime Capital
backs ArtBio
Meta Planet
backs Luminate Medical
Better Capital
backs ZenOnco
Similar startupsby what they do, their industry and backers
CarcinotechVenture round · this month · Founded 2018 · 201-500 employees
Carcinotech revolutionizes preclinical oncology services with 3D-bioprinted tumor models, advancing cancer research and precision medicine…
ArtBioSeries B $132M · 15 mo ago · Founded 2021 · 201-500 employees · 4 roles
Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize…
OncoLensSeries A $7.3M · 5 yr ago · 51-200 employees
OncoLens is the multidisciplinary cancer care platform for tumor boards, registry automation, AI patient identification, and oncology…
Luminate MedicalVenture round $19.4M · 10 mo ago · Founded 2019 · 51-200 employees
We deliver cutting edge cancer care in the home - reducing costs for patients, providers, and payers.
Karkinos Healthcare Private Limited
Prevention to Recovery Comprehensive Cancer Care Solutions From early detection and diagnosis to treatment and wellness all under one roof…
OncoBrain
Clinical intelligence that thinks like an oncologist. Guideline-concordant decision support for cancer care.

Growth

Hiring Momentum
23/100
Hiring freeze
Open positions
0
0 opened / 0 closed in 30 days
Median time-to-fill
70 days
faster than 17% of the market
ATS activity
Every ~9 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Operations
100% ▼

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
M VenturesVia a fund
73 portfolio companies: Neurable, Mosa Meat, Wiliot and 70 more
Sofinnova PartnersVia a fund
129 portfolio companies: IMIO, Alethio Therapeutics, Reyva and 126 more
Report a mistake

News

News YahooFinance 3 years ago
iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023
Discovery of novel immune checkpoints in the tumor microenvironment with iOTarg screening platformPredictive biomarker signature for lead product candidate OMX-0407 MUNICH, Germany, March 15, 2023 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG, a biopharmaceuti
Read more
Report